TMCnet News

Research and Markets: Huntington's Disease Forecast 2015-2025 - Delivery of More Accurate Information for Clinical Trials in Study Sizing and Realistic Patient Recruitment
[August 14, 2015]

Research and Markets: Huntington's Disease Forecast 2015-2025 - Delivery of More Accurate Information for Clinical Trials in Study Sizing and Realistic Patient Recruitment


Research and Markets (http://www.researchandmarkets.com/research/3jc3gj/epiomic) has announced the addition of the "Epiomic Epidemiology Series: Huntington's Disease Forecast in 8 Major Markets 2015-2025" report to their offering.

Epiomic Epidemiology Series:  8 Major Markets 2015-2025

Presented in an easy to understand table format, this report provides the current prevalent population for Huntington's disease across 8 Major Markets (USA, France, Germany, Italy, Spain, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a 10-year forecast projection based on population trends in each of the major markets. The report also contains a disease overview including risk factors, disease diagnosis and prognosis along with specific variations by geography and ethniity.




The report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.

Reason to Purchase:

  • Able to quantify patient populations in the global Huntington's disease market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of WG and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

Key Topics Covered:


1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) &Clinical Course

7. Unified Huntington's Disease Rating Scale (UHDRS)

8. Total Functional Capacity

9. Methodology

10. Top-Line Huntington's Disease Prevalence

11. Prevalence of UHDRS Components within the Huntington's Disease Cohort

12. References

13. Appendix

For more information visit http://www.researchandmarkets.com/research/3jc3gj/epiomic


[ Back To TMCnet.com's Homepage ]